Role of TNF-α in the mechanisms responsible for preterm delivery induced by Stx2 in rats

British Journal of Pharmacology

Volumn 168, Issue 4, 2013, Pages 946-953

  Burdet, Juliana ^a   Sacerdoti, Flavia ^a   Cella, Maximiliano ^b   Franchi, Ana M ^b   Ibarra, Cristina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

cyclooxygenases; nitric oxide; nitric oxide synthase; pregnant rats; preterm delivery; prostaglandins; Stx2 treatment; tumour necrosis factor

Indexed keywords

AMINOGUANIDINE; CYCLOOXYGENASE 2; ETANERCEPT; MELOXICAM; NITRIC OXIDE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; TUMOR NECROSIS FACTOR ALPHA; VEROTOXIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DECIDUA; FEMALE; NONHUMAN; PLACENTA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CYCLOOXYGENASE 2; DECIDUA; DINOPROST; DINOPROSTONE; DRUG THERAPY, COMBINATION; FEMALE; GUANIDINES; IMMUNOGLOBULIN G; NITRIC OXIDE; PLACENTA; PREGNANCY; PREMATURE BIRTH; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; SHIGA TOXIN 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872906655     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02239.x     Document Type: Article

References (37)

1. Aisemberg J, Vercelli C, Billi S, Ribeiro ML, Ogando D, Meiss R, et al. (2007). Nitric oxide mediates prostaglandins' deleterious effect on lipopolysaccharide-triggered murine fetal resorption. Proc Natl Acad Sci USA 104: 7534-7539.
2. Burdet J, Zotta E, Franchi AM, Ibarra C, (2009). Intraperitoneal administration of Shiga toxin type 2 in rats in the late stage of pregnancy produces premature delivery of dead fetuses. Placenta 30: 491-496.
3. Burdet J, Zotta E, Cella M, Franchi AM, Ibarra C, (2010). Role of nitric oxide in Shiga toxin-2-induced premature delivery of dead fetuses in rats. Plos ONE 5: e15127.
4. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K, (1988). Site of action of a Vero toxin (VT2) from Escherichia coli O157: H7 and Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171: 45-50.
5. Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, et al. (2011). Epidemic profile of Shiga-toxin-producing Escherichia coli O104: H4 outbreak in Germany. N Engl J Med 365: 1771-1780.
6. Fraser ME, Chernaia MM, Kozlov YV, James MNG, (1994). Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 Å resolution. Nat Struct Biol 1: 59-64.
7. Gianantonio C, Vitacco M, Mendizharzu F, Rutty A, (1964). The hemlytic-uremic syndrome. J Pediatr 64: 478-491.
8. Goldstein J, Loidl CF, Pistone Creydt V, Boccoli J, Ibarra C, (2007). Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study. Brain Res 1161: 106-115.
9. Gravett MG, Adams KM, Sadowsky DW, Grosvenor AR, Witkin SS, Axthelm MK, et al. (2007). Immunomodulators plus antibiotics delay preterm delivery after experimental intraamniotic infection in a nonhuman primate model. Am J Obstet Gynecol 197: 518.e1-518.e8.
10. Grigsby PL, Hirst JJ, Scheerlinck JP, Phillips DJ, Jenkin G, (2003). Fetal responses to maternal and intra-Amniotic lipopolysaccharide administration in sheep. Biol Reprod 68: 1695-1702.
11. Ibarra C, Palermo M, (2010). Host responses to pathogenic Escherichia coli. Cap 9. In:, Torres A, (ed.). Pathogenic Escherichia Coli in Latin America, 1st edn. Betham Publ: University of Texas, TX, pp. 122-141. Available at: http://www.bentham.org/ebooks/9781608051922/index.htm (accessed 28 November 2012).
12. Inglis SR, Jeremias J, Kuno K, Lescale K, Peeper Q, Chervenak FA, et al. (1994). Detection of tumor necrosis factor-Alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol 171: 5-10.
13. Karmali MA, Steele BT, Petric M, Lim C, (1983). Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1: 619-620.
14. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
15. Landoni VI, de Campos-Nebel M, Schierloh P, Calatayud C, Fernandez GC, Lapponi ML, et al. (2010). Shiga toxin 1-induced inflammatory response in lipopolysaccharide-sensitized astrocytes is mediated by endogenous tumor necrosis factor alpha. Infect Immun 78: 1193-1201.
16. Lingwood CA, (1996). Role of verotoxin receptors in pathogenesis. Trends Microbiol 4: 147-153.
17. Lingwood CA, Law H, Richardson S, Petric M, Brunton JL, De Grandis S, et al. (1987). Glycolipid binding of purified and recombinant Escherichia coli-produced verotoxin in vitro. J Biol Chem 262: 8834-8839.
18. Louise CB, Obrig TG, (1991). Shiga toxin-Associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro. Infect Immun 59: 4173-4179.
19. Louise CB, Obrig TG, (1992). Shiga toxin-Associated hemolytic uremic syndrome: combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 60: 1536-1543.
20. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
21. Paton JC, Paton AW, (1998). Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11: 450-479.
22. Peltier MR, (2003). Immunology of term and preterm labor. Reprod Biol Endocrinol 1: 122.
23. Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R, (2000). Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 15: 713-718.
24. Renaud SJ, Cotechini T, Quirt JS, Macdonald-Goodfellow M, Othman M, Graham CH, (2011). Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. J Immunol 186: 1799-1808.
25. Repetto HA, (1997). Epidemic hemolytic-uremic syndrome in children. Nephrology Forum. Kidney Int 52: 1708-1719.
26. Ribeiro ML, Aisemberg J, Billi S, Farina MG, Meiss R, McCann S, et al. (2005). Epidermal growth factor prevents prepartum luteolysis in the rat. Proc Natl Acad Sci USA 102: 8048-8053.
27. Richardson SE, Karmali MA, Becker LE, Smith CR, (1988). The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli. Hum Pathol 19: 1102-1110.
28. Rivas M, Miliwebsky E, Chinen I, Deza N, Leotta G, (2006). The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission. Medicina (B Aires) 66: 27-32.
29. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzum E, Mitchell MD, et al. (1988). Infection in the pathogenesis of preterm labor. Semin Perinatol 12: 262-279.
30. Sato TA, Keelan JA, Mitchell MD, (2003). Critical paracrine interactions between TNF-α and IL-10 regulate pipopolysaccharide-stimulated human choriodecidual cytokine and prostaglandin E2 production. J Immunol 170: 158-166.
31. Scully RE, Mark EJ, McNeely WF, Ebeling SH, Phillips LD, (1995). Case records of the Massachusetts General Hospital. N Engl J Med 336: 1587-1594.
32. Shiau MY, Chiou HL, Lee YL, Kuo TM, Chang YH, (2001). Establishment of a consistent L929 bioassay system for TNF-Alpha quantitation to evaluate the effect of lipopolysaccharide, phytomitogens and cytodifferentiation agents on cytotoxicity of TNF-Alpha secreted by adherent human mononuclear cells. Mediators Inflamm 10: 199-208.
33. Silen ML, Firpo A, Morgello S, Lowry SF, Francus T, (1989). Interleukin-1 alpha and tumor necrosis factor alpha cause placental injury in the rat. Am J Pathol 135: 239-244.
34. Silver RM, Lohner WS, Daynes RA, Mitchell MD, Branch DW, (1994). Lipopolysaccharide-induced fetal death: the role of tumor-necrosis factor alpha. Biol Reprod 50: 1108-1112.
35. Steele BT, Goldie J, Alexopoluou I, Shimizu A, (1984). Post-partum haemolytic uraemic syndrome and verotoxin-producing Escherichia coli. Lancet 1: 511.
36. Strauss RC, Alexander RW, (1976). Post-partum hemolytic uremic syndrome. Obstet Gynecol 47: 169-173.
37. Tesh VL, Ramegowda B, Samuel JE, (1994). Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun 62: 5085-5094.